MiLaboratories

MiLaboratories develops high-performance software platforms that empower biologists to independently analyze next-generation sequencing (NGS) data. Their Platforma.bio SDK streamlines genomic data analysis, reducing reliance on bioinformaticians and accelerating drug discovery. This user-friendly platform automates resource management and complex processes, making advanced computational biology tools accessible to a wider range of researchers.

Funding Round: Series A

Funding Amount: $10M

Date: 10-Oct-2024

Investors: Kfund, Speedinvest, Acrobator Ventures, Ten13, Somersault Ventures, EGB Capital, Courtyard Ventures

Markets: Biotechnology, Genomics, Computational Biology, Pharmaceuticals, Software, Genetics

HQ: San Francisco, California, United States

Founded: 2021

Website: https://milaboratories.com/

LinkedIn: https://www.linkedin.com/company/milaboratories

Twitter: https://twitter.com/_mixcr_

Instagram:

Facebook: